Annamaria Lanzillotta

Brescia, 25123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.

NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.

Journal: Neurobiology of disease

Published: October 17, 2022

Role of the TAp63 Isoform in Recurrent Nasal Polyps.

Role of the TAp63 Isoform in Recurrent Nasal Polyps.

Journal: Folia biologica

Published: January 07, 2020

A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia.

A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia.

Journal: Nutrients

Published: December 12, 2018

NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice.

NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice.

Journal: Translational neurodegeneration

Published: September 25, 2018

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.

Journal: International journal of molecular sciences

Published: November 10, 2017

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.

Journal: International journal of molecular sciences

Published: October 11, 2016

PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia.

PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia.

Journal: Brain research

Published: March 02, 2016

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.

Journal: Frontiers in neurology

Published: December 30, 2014

CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.

CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.

Journal: Neuroscience

Published: July 30, 2014

Pharmacological targeting of the β-amyloid precursor protein intracellular domain.

Pharmacological targeting of the β-amyloid precursor protein intracellular domain.

Journal: Scientific reports

Published: December 31, 2013

Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia.

Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia.

Journal: Pharmacological research

Published: November 15, 2013

Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.

Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.

Journal: Neurobiology of disease

Published: April 03, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026